Cargando…

Serological and Molecular Evidence of Patients Infected with Anaplasma phagocytophilum in Mexico

Human granulocytic Anaplasmosis (HGA), is a tick-borne infectious disease transmitted by ticks, resulting in acute feverish episodes. The etiological agent is the bacteria Anaplasma phagocytophilum; which is spread by ticks of the genus Ixodes spp. to complete its life cycle. In Mexico, there is onl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sosa-Gutierrez, Carolina Guadalupe, Cervantes-Castillo, Maria Almudena, Laguna-Gonzalez, Ramon, Lopez-Echeverria, Laura Yareli, Ojeda-Ramírez, Deyanira, Oyervides, Mayra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161817/
https://www.ncbi.nlm.nih.gov/pubmed/34069232
http://dx.doi.org/10.3390/diseases9020037
_version_ 1783700582993756160
author Sosa-Gutierrez, Carolina Guadalupe
Cervantes-Castillo, Maria Almudena
Laguna-Gonzalez, Ramon
Lopez-Echeverria, Laura Yareli
Ojeda-Ramírez, Deyanira
Oyervides, Mayra
author_facet Sosa-Gutierrez, Carolina Guadalupe
Cervantes-Castillo, Maria Almudena
Laguna-Gonzalez, Ramon
Lopez-Echeverria, Laura Yareli
Ojeda-Ramírez, Deyanira
Oyervides, Mayra
author_sort Sosa-Gutierrez, Carolina Guadalupe
collection PubMed
description Human granulocytic Anaplasmosis (HGA), is a tick-borne infectious disease transmitted by ticks, resulting in acute feverish episodes. The etiological agent is the bacteria Anaplasma phagocytophilum; which is spread by ticks of the genus Ixodes spp. to complete its life cycle. In Mexico, there is only one case report. The primary challenge is understanding how other bacteria affect or overlap with the clinical manifestation of the disease. Sample collection occurred over the period September 2017 through October 2019. Blood samples from human subjects were obtained immediately after they signed consent forms. We analyzed for the presence for A. phagocytophilum by serological (IFA IgG two times) and PCR targeting 16SrRNA and groEL genes, followed by DNA sequencing. All patients with a history of travel abroad were dismissed for this project. In total, 1924 patients participated and of these, 1014 samples across the country were analyzed. Of these, 85 (8.38%) had IFA results that ranged from 1:384 to 1:896. Of the positive samples, 7.10% were used for PCR. Significant clinical manifestations included: dizziness, nausea, petechial, epistaxis, enlarged liver and/or spleen and thrombocytopenia. Hospitalization of at least 1.5 days was necessary for 3.2% of patients. None of the cases analyzed were lethal. This is the first clinical manifestations along with serological test results and molecular analysis confirmed the presence of A. phagocytophilum resulting in HGA in patients from Mexico. Health institutions and medical practitioners in general should include diagnostic testing for HGA among high risk populations and should recognize it as a vector-borne emerging infectious disease in Mexico.
format Online
Article
Text
id pubmed-8161817
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81618172021-05-29 Serological and Molecular Evidence of Patients Infected with Anaplasma phagocytophilum in Mexico Sosa-Gutierrez, Carolina Guadalupe Cervantes-Castillo, Maria Almudena Laguna-Gonzalez, Ramon Lopez-Echeverria, Laura Yareli Ojeda-Ramírez, Deyanira Oyervides, Mayra Diseases Article Human granulocytic Anaplasmosis (HGA), is a tick-borne infectious disease transmitted by ticks, resulting in acute feverish episodes. The etiological agent is the bacteria Anaplasma phagocytophilum; which is spread by ticks of the genus Ixodes spp. to complete its life cycle. In Mexico, there is only one case report. The primary challenge is understanding how other bacteria affect or overlap with the clinical manifestation of the disease. Sample collection occurred over the period September 2017 through October 2019. Blood samples from human subjects were obtained immediately after they signed consent forms. We analyzed for the presence for A. phagocytophilum by serological (IFA IgG two times) and PCR targeting 16SrRNA and groEL genes, followed by DNA sequencing. All patients with a history of travel abroad were dismissed for this project. In total, 1924 patients participated and of these, 1014 samples across the country were analyzed. Of these, 85 (8.38%) had IFA results that ranged from 1:384 to 1:896. Of the positive samples, 7.10% were used for PCR. Significant clinical manifestations included: dizziness, nausea, petechial, epistaxis, enlarged liver and/or spleen and thrombocytopenia. Hospitalization of at least 1.5 days was necessary for 3.2% of patients. None of the cases analyzed were lethal. This is the first clinical manifestations along with serological test results and molecular analysis confirmed the presence of A. phagocytophilum resulting in HGA in patients from Mexico. Health institutions and medical practitioners in general should include diagnostic testing for HGA among high risk populations and should recognize it as a vector-borne emerging infectious disease in Mexico. MDPI 2021-05-14 /pmc/articles/PMC8161817/ /pubmed/34069232 http://dx.doi.org/10.3390/diseases9020037 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sosa-Gutierrez, Carolina Guadalupe
Cervantes-Castillo, Maria Almudena
Laguna-Gonzalez, Ramon
Lopez-Echeverria, Laura Yareli
Ojeda-Ramírez, Deyanira
Oyervides, Mayra
Serological and Molecular Evidence of Patients Infected with Anaplasma phagocytophilum in Mexico
title Serological and Molecular Evidence of Patients Infected with Anaplasma phagocytophilum in Mexico
title_full Serological and Molecular Evidence of Patients Infected with Anaplasma phagocytophilum in Mexico
title_fullStr Serological and Molecular Evidence of Patients Infected with Anaplasma phagocytophilum in Mexico
title_full_unstemmed Serological and Molecular Evidence of Patients Infected with Anaplasma phagocytophilum in Mexico
title_short Serological and Molecular Evidence of Patients Infected with Anaplasma phagocytophilum in Mexico
title_sort serological and molecular evidence of patients infected with anaplasma phagocytophilum in mexico
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161817/
https://www.ncbi.nlm.nih.gov/pubmed/34069232
http://dx.doi.org/10.3390/diseases9020037
work_keys_str_mv AT sosagutierrezcarolinaguadalupe serologicalandmolecularevidenceofpatientsinfectedwithanaplasmaphagocytophiluminmexico
AT cervantescastillomariaalmudena serologicalandmolecularevidenceofpatientsinfectedwithanaplasmaphagocytophiluminmexico
AT lagunagonzalezramon serologicalandmolecularevidenceofpatientsinfectedwithanaplasmaphagocytophiluminmexico
AT lopezecheverrialaurayareli serologicalandmolecularevidenceofpatientsinfectedwithanaplasmaphagocytophiluminmexico
AT ojedaramirezdeyanira serologicalandmolecularevidenceofpatientsinfectedwithanaplasmaphagocytophiluminmexico
AT oyervidesmayra serologicalandmolecularevidenceofpatientsinfectedwithanaplasmaphagocytophiluminmexico